Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3560-3568

  Özyilmaz, Akin ^a   Bakker, Stephan J L ^a   De Zeeuw, Dick ^a   De Jong, Paul E ^a   Gansevoort, Ronald T ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Albuminuria; Cardiovascular risk factors; Screening

Indexed keywords

ALBUMIN; GLUCOSE;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; SCREENING; SENSITIVITY AND SPECIFICITY; URINALYSIS; CARDIOVASCULAR DISEASE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; URINE;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79952201955     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq478     Document Type: Article

References (54)

1. Hadden WC, Harris MI. Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age. Vital Health Stat 1987; 11: 1-55
2. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-1268 (Pubitemid 44125920)
3. Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-69
4. Creagh D, Neilson S, Collins A et al. Established cardiovascular disease and CVD risk factors in a primary care population of middleaged Irish men and women. Ir Med J 2002; 95: 298-301
5. Smith WC, Lee AJ, Crombie IK et al. Control of blood pressure in Scotland: The rule of halves. BMJ 1990; 300: 981-983 (Pubitemid 20144227)
6. British family heart study: Its design and method, and prevalence of cardiovascular risk factors. Family heart study group. Br J Gen Pract 1994; 44: 62-67
7. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
8. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906 (Pubitemid 28516321)
9. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
10. Atkins RC, Polkinghorne KR, Briganti EM et al. Prevalence of albuminuria in Australia: The AusDiab Kidney Study. Kidney Int Suppl 2004; S22-S24
11. Joshi VD, Mooppil N, Lim J. Prevalence and risk factors of undetected proteinuria in an elderly South-East Asian population. Nephrology 2006; 11: 347-354 (Pubitemid 44086881)
12. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria and stroke in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004; 255: 247-256 (Pubitemid 38241369)
13. Hillege HL, Janssen WM, Bak AA et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526 (Pubitemid 32823860)
14. Pruijm MT, Madeleine G, Riesen WF et al. Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens 2008; 26: 871-877 (Pubitemid 351520973)
15. Choi HS, Ryu SH, Lee KB. The relationship of microalbuminuria with metabolic syndrome. Nephron Clin Pract 2006; 104: C85-c93
16. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35 (Pubitemid 38880131)
17. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2: 581-590
18. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17: 2100-2105 (Pubitemid 44141898)
19. Pontremoli R, Leoncini G, Ravera M et al. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J Am Soc Nephrol 2002; 13: S169-S172 (Pubitemid 35216019)
20. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782
21. Jafar TH, Chaturvedi N, Hatcher J et al. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. Nephrol Dial Transplant 2007; 22: 2194-2200 (Pubitemid 47244696)
22. Gansevoort RT, Verhave JC, Hillege HL et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005; S28-S35
23. Atthobari J, Asselbergs FW, Boersma C et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 2006; 28: 432-444 (Pubitemid 43783432)
24. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168: 897-905
25. Mahmoodi BK, Gansevoort RT, Veeger NJ et al. Microalbuminuria and risk of venous thromboembolism. JAMA 2009; 301: 1790-1797
26. Ramsay L, Williams B, Johnston G et al. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-592 (Pubitemid 29438528)
27. Chalmers J, MacMahon S, Mancia G et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009-1060 (Pubitemid 29325497)
28. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572 (Pubitemid 37430158)
29. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20
30. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
31. Pearson TA, Bowlin S, Sigmund WR. Screening for hypercholesterolemia. Annu Rev Med 1990; 41: 177-186 (Pubitemid 20121725)
32. Pignone MP, Phillips CJ, Atkins D et al. Screening and treating adults for lipid disorders. Am J Prev Med 2001; 20: 77-89 (Pubitemid 33732971)
33. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24: 987-1003 (Pubitemid 36712275)
34. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 (Pubitemid 29135798)
35. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100 (Pubitemid 41623371)
36. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375: 2073-2081
37. Coresh J, Byrd-Holt D, Astor BC et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188 (Pubitemid 43073171)
38. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624 (Pubitemid 29135163)
39. Pinto-Sietsma SJ, Janssen WM, Hillege HL et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000; 11: 1882-1888
40. Brantsma AH, Bakker SJ, Hillege HL et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005; 28: 2525-2530 (Pubitemid 41384305)
41. Halimi JM, Bonnet F, Lange C et al. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 2008; 26: 2198-2206
42. Brantsma AH, Bakker SJ, de Zeeuw D et al. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006; 17: 331-335
43. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-1376 (Pubitemid 40396802)
44. Verhave JC, Gansevoort RT, Hillege HL et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl 2004; S18-S21
45. Boersma C, Gansevoort RT, Pechlivanoglou P et al. Screen-andtreat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. Clin Ther 2010; 32: 1103-1121
46. Bigazzi R, Bianchi S, Baldari D et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325-1333 (Pubitemid 28408416)
47. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997 (Pubitemid 29379934)
48. Brantsma AH, Bakker SJ, Hillege HL et al. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: The importance of urinary albumin excretion. Nephrol Dial Transplant 2008; 23: 3851-3858
49. Ishani A, Grandits GA, Grimm RH et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 2006; 17: 1444-1452 (Pubitemid 43673426)
50. Hallan SI, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077
51. Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496 (Pubitemid 350254909)
52. Iseki K, Kinjo K, Iseki C et al. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44: 806-814 (Pubitemid 39445912)
53. Jensen JS, Feldt-Rasmussen B, Strandgaard S et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903 (Pubitemid 30303947)
54. Boersma C, Postma MJ, Visser ST et al. Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. Br J Clin Pharmacol 2008; 65: 723-732 (Pubitemid 351545792)